Daré Bioscience, Inc.

NasdaqCM:DARE Rapporto sulle azioni

Cap. di mercato: US$35.6m

Daré Bioscience Dividendo

Dividendo criteri di controllo 0/6

Daré Bioscience does not have a record of paying a dividend.

Informazioni chiave

n/a

Rendimento del dividendo

-26.1%

Rendimento del riacquisto

Rendimento totale per gli azionisti-26.1%
Rendimento futuro dei dividendin/a
Crescita dei dividendin/a
Prossima data di pagamento dei dividendin/a
Data di stacco del dividendon/a
Dividendo per azionen/a
Rapporto di remunerazionen/a

Aggiornamenti recenti sui dividendi

Nessun aggiornamento

Recent updates

We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

Nov 07
We're A Little Worried About Daré Bioscience's (NASDAQ:DARE) Cash Burn Rate

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Jul 21
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Mar 12
Is Daré Bioscience (NASDAQ:DARE) In A Good Position To Invest In Growth?

Daré rises on positive data from early-to-mid-stage trial of intravaginal ring to treat menopause symptoms

Oct 17

Daré Bioscience rises as company submits application to begin trial of non-hormonal contraceptive

Oct 10

Dare Bioscience reports positive progress for cream for female sexual arousal disorder

Aug 29

Daré Bioscience signs agreement with Organon for bacterial vaginosis therapy

Jun 30

Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Apr 02
Will Daré Bioscience (NASDAQ:DARE) Spend Its Cash Wisely?

Diving Back Into Daré Bioscience Again

Jan 07

We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Nov 26
We Think Daré Bioscience (NASDAQ:DARE) Needs To Drive Business Growth Carefully

Daré Bioscience's DARE-BV1 shows positive action in late-stage bacterial vaginosis study

Apr 26

Diving Into Daré Bioscience

Jan 31

Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dec 22
Why Daré Bioscience, Inc. (NASDAQ:DARE) Could Be Worth Watching

Dare Bioscience EPS misses by $0.06

Nov 12

Stabilità e crescita dei pagamenti

Recupero dei dati sui dividendi

Dividendo stabile: Insufficient data to determine if DARE's dividends per share have been stable in the past.

Dividendo in crescita: Insufficient data to determine if DARE's dividend payments have been increasing.


Rendimento dei dividendi rispetto al mercato

Daré Bioscience Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di DARE rispetto al mercato?
SegmentoRendimento dei dividendi
Azienda (DARE)n/a
Fondo del 25% del mercato (US)1.5%
Top 25% del mercato (US)4.5%
Media del settore (Pharmaceuticals)2.3%
Analista previsionale (DARE) (fino a 3 anni)n/a

Dividendo notevole: Unable to evaluate DARE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Dividendo elevato: Unable to evaluate DARE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Distribuzione degli utili agli azionisti

Copertura degli utili: Insufficient data to calculate DARE's payout ratio to determine if its dividend payments are covered by earnings.


Pagamenti in contanti agli azionisti

Copertura del flusso di cassa: Unable to calculate sustainability of dividends as DARE has not reported any payouts.


Scoprire le società che pagano dividendi forti